SCHEMBL9986285

SCHEMBL9986285

CC(C(=O)O)(C(=O)O)c1ccc(-c2ccc(C(C)(C(=O)O)C(=O)O)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.50
RXRA P19793 5/20 0.44
RXRB P28702 5/20 0.44
RXRG P48443 3/20 0.44
KIF11 P52732 2/20 0.42
MAPT P10636 2/20 0.41
KMT2A Q03164 1/20 0.41
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
APP P05067 1/20 0.40
SRD5A2 P31213 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
PTPN5 P54829 1/20 0.38
CYP2D6 P10635 1/20 0.38
HIF1A Q16665 1/20 0.38
FFAR1 O14842 1/20 0.38
DHODH Q02127 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3087883 0.93 CYP2C9 (0.61) CYP2C9RXRARXRBKIF11MAPT
SCHEMBL2481923 0.83 TSHR (0.50) KIF11MAPTSRD5A2SMN1; SMN2
SCHEMBL7067690 0.83 ESR1 (0.54)
SCHEMBL1560417 0.82 MAPT (0.54) CYP2C9MAPTKMT2ACYP2D6HIF1A
SCHEMBL27609150 0.81 NPC1 (0.48) MAPTKMT2ASMN1; SMN2
SCHEMBL11625903 0.81 KMT2A (0.54) CYP2C9MAPTKMT2ASMN1; SMN2CYP2D6
SCHEMBL7361290 0.81 MEN1 (0.41) CYP2C9KIF11KMT2ASRD5A2SMN1; SMN2
SCHEMBL21269891 0.80 MAPT (0.52) CYP2C9MAPTKMT2ACYP2D6HIF1A
SCHEMBL21269958 0.80 MAPT (0.52) CYP2C9MAPTKMT2ACYP2D6HIF1A
SCHEMBL21269860 0.80 MAPT (0.52) CYP2C9MAPTKMT2ACYP2D6HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397504-A1 (METH)ACRYLATE COMPOUND CONTAINING AROMATIC GROUP Showa Denko K.K. (JP) 2011-12-21 EP disclosed
US-20110294948-A1 AROMATIC GROUP-CONTAINING (METH) ACRYLATE COMPOUND SHOWA DENKO K.K. (JP) 2011-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294948-A1 AROMATIC GROUP-CONTAINING (METH) ACRYLATE COMPOUND ACR, MMAB, ATR CYP2C9 1312/4885RXRA 1725/4885RXRB 2215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.